Brief: Corline Biomedical And Imperative Care Ink Cooperation Deal
May 4 (Reuters) - Corline Biomedical AB CLBIO.ST :
* CO AND IMPERATIVE CARE ENETER INTO LICENSE- AND DELIVERY
AGREEMENT
* PRODUCTS HAVE POTENTIAL TO GENERATE REVENUE OF ABOUT SEK
150
MLNPR YEAR, MORE THAN SEK 1 BILLION IN TOTAL
* UNDER NOW SIGNED AGREEMENT, CORLINE RECEIVES UP TO SEK 140
MILLION IN COMBINATION OF EXCLUSIVITY AND MILESTONE PAYMENTS AS
WELL COMPENSATION FOR DEVELOPMENT COSTS
Source text for Eikon: ID:nGNE8pQLXf
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln